Lembo AJ - Search Results

1

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.

Chey WD, Lembo AJ, Rosenbaum DP. Chey WD, et al. Among authors: lembo aj. Am J Gastroenterol. 2017 May;112(5):763-774. doi: 10.1038/ajg.2017.41. Epub 2017 Feb 28. Am J Gastroenterol. 2017. PMID: 28244495 Free PMC article. Clinical Trial.

2

Neurotrophin-3 improves functional constipation.

Parkman HP, Rao SS, Reynolds JC, Schiller LR, Wald A, Miner PB, Lembo AJ, Gordon JM, Drossman DA, Waltzman L, Stambler N, Cedarbaum JM; Functional Constipation Study Investigators. Parkman HP, et al. Among authors: lembo aj. Am J Gastroenterol. 2003 Jun;98(6):1338-47. doi: 10.1111/j.1572-0241.2003.t01-1-07477.x. Am J Gastroenterol. 2003. PMID: 12818279 Clinical Trial.

3

Irritable bowel syndrome: evaluation and treatment.

Somers SC, Lembo A. Somers SC, et al. Gastroenterol Clin North Am. 2003 Jun;32(2):507-29. doi: 10.1016/s0889-8553(03)00022-0. Gastroenterol Clin North Am. 2003. PMID: 12858604 Review.

4

Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder.

Lembo A, Weber HC, Farraye FA. Lembo A, et al. Drugs. 2003;63(18):1895-905. doi: 10.2165/00003495-200363180-00002. Drugs. 2003. PMID: 12930162 Review.

5

Tegaserod does not alter fasting or meal-induced biliary tract motility.

Fisher RS, Thistle J, Lembo A, Novick J, O'Kane P, Chey WD, Beglinger C, Rueegg P, Shi V, Dogra A, Luo D, Earnest DL. Fisher RS, et al. Am J Gastroenterol. 2004 Jul;99(7):1342-9. doi: 10.1111/j.1572-0241.2004.30301.x. Am J Gastroenterol. 2004. PMID: 15233676 Free article. Clinical Trial.

6

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials.

Lembo AJ, Olden KW, Ameen VZ, Gordon SL, Heath AT, Carter EG. Lembo AJ, et al. Clin Gastroenterol Hepatol. 2004 Aug;2(8):675-82. doi: 10.1016/s1542-3565(04)00284-8. Clin Gastroenterol Hepatol. 2004. PMID: 15290660 Clinical Trial.

7

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.

Johanson JF, Wald A, Tougas G, Chey WD, Novick JS, Lembo AJ, Fordham F, Guella M, Nault B. Johanson JF, et al. Among authors: lembo aj. Clin Gastroenterol Hepatol. 2004 Sep;2(9):796-805. doi: 10.1016/s1542-3565(04)00356-8. Clin Gastroenterol Hepatol. 2004. PMID: 15354280 Clinical Trial.

8

Irritable bowel syndrome medications side effects survey.

Lembo A. Lembo A. J Clin Gastroenterol. 2004 Oct;38(9):776-81. doi: 10.1097/01.mcg.0000139029.00451.c7. J Clin Gastroenterol. 2004. PMID: 15365404

9

Review of tegaserod in the treatment of irritable bowel syndrome.

Patel S, Berrada D, Lembo A. Patel S, et al. Expert Opin Pharmacother. 2004 Nov;5(11):2369-79. doi: 10.1517/14656566.5.11.2369. Expert Opin Pharmacother. 2004. PMID: 15500384 Review.

10

The placebo effect in irritable bowel syndrome trials: a meta-analysis.

Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, Canenguez K, Park JK, Kelly E, Jacobson E, Kerr CE, Lembo AJ. Patel SM, et al. Among authors: lembo aj. Neurogastroenterol Motil. 2005 Jun;17(3):332-40. doi: 10.1111/j.1365-2982.2005.00650.x. Neurogastroenterol Motil. 2005. PMID: 15916620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page